期刊文献+

PREPARATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODY AGAINST HUMAN TELOME RASE REVERSE TRANSCRIPTASE

PREPARATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODY AGAINST HUMAN TELOME RASE REVERSE TRANSCRIPTASE
下载PDF
导出
摘要 Objective.To develop monoclonal antibodies again st the catalytic subunit of human telomerase reverse transcriptasefor i ts expression detection of human tumors.Methods.A dominant epitope in hTERT was automatically synthesized based on Fmoc method,and was used to immuni ze Balb/c mice.Hybridomas were generated and screened by ELISA for specific mo noclonal antibodies,and the characterization was performed by Western blotting and immunohistochemical staining.The heavy chain variable region of antibody wa s cloned by RT-PCR and sequenced.Results.Antigenic peptide hTERT 7 was synthesized and confirmed by MALDI-TOF-MS and HPLC analysis.One hybr idoma cell line secreting anti-hTERT 7 antibodies designated as M2was established after primary screening and cons equent 3rounds of limited dilution.M2was IgG1in isotyping.The competi-tive assay showed that the M2antibody was hTERT 7-specific,and the affinity constant was about 1×10 6 mol-1 .The antibody reacted with cell extracts from HeLa cancer cells but not wi th those from normal2BS cells in ELISA assay.For in situ staining of immunohis tochemistry,the positive staining presented in the nuclear compartment of HeLa ,while2BS was negative.The heavy chain variable region from M2re-vealed tha t the monoclonal antibody was mouse origin.Conclusions.The developed mouse mon oclonal antibody is hTERT-specific and able to recognize native cellular hTERT in ELISA and immunohistochemistry,which makes the immuno-detection of telom-e rase hTERT expression in cancer cells or tissues possible.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2003年第3期143-149,共7页 中国医学科学杂志(英文版)
关键词 TELOMERASE human telomerase reverse tran scriptase monoclonal antibody 人端粒酶反转录酶 单克隆抗体 肿瘤 酶联免疫吸附实验
  • 相关文献

参考文献11

  • 1Shay JW, Bacchetti S. A survey of telomerase activation in human cancer. Eur J Cancer 1997; 33: 787-91.
  • 2Kim NW, Shay JW, Woodring E, et al. Telomerase activity in human cancer. Cancer Biol 1996; 8: 66-71.
  • 3Feng JL, Fun WD, Wang SS, et al. The RNA component of telomerase. Science 1995; 269: 1236-9.
  • 4Nakayama J, Saito M, Nakamura H, et al. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997; 88: 875-84.
  • 5Meyerson M, Counter MC, Eaton NE, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
  • 6Liu Y, Snow BE, Hande MP, et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curt Biol 2000; 10 (22): 1459-62.
  • 7Koyanagi Y, Kobayashi D, Yajima T, et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemia ceils. Anticancer Res 2000; 20(2A): 773-8.
  • 8Yan SM, Zhang B, Wang JM, et al. Monoclonal antibodies against human telomerase reverse transcriptase (hTERT):preparation, characterization and application. Hybridoma 2001 ; 20(4) : 249-55.
  • 9Ausubel FM, Brent R, Kingston RE, et al. Short protocols in molecular biology. 3rd ed. New York: John Wiley & Sons Press; 1995. p.104-5.
  • 10Orlandi R, Gussow TD, Jones TP, et al. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Nail Acad Sci USA 1989; 86:3833-7.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部